Pulse Explorar nav.journalClub Debates Tendencias Investigadores

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Inicio Explorar nav.journalClub Tendencias

⌘+K

May 3, 2023Open Access

Treatment decisions in VRE bacteraemia: a survey of infectious diseases pharmacists

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

ID pharmacists overwhelmingly selected high-dose daptomycin for VRE BSI. There were variations in practice and response rate when selecting combination therapy, managing persistent bacteraemia, and treating patients with high daptomycin MICs or previous exposure to daptomycin.

Leer artículo completoexternamente

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Cite This Study

White et al. (Wed,) studied this question.

synapsesocial.com/papers/69d8800a8c03fbaff8bef462 https://doi.org/https://doi.org/10.1093/jacamr/dlad063

Treatment decisions in VRE bacteraemia: a survey of infectious diseases pharmacists | Synapse